Onyx Pharmaceuticals buy wiltrud
Start price
30.03.12
/
50%
€28.37
Target price
25.04.12
€34.50
Performance (%)
23.94%
End price
25.04.12
€35.16
Summary
This prediction ended on 25.04.12 with a price of €35.16. The BUY prediction by wiltrud finished with a performance of 23.94%. wiltrud has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Onyx Pharmaceuticals | - | - | - | - |
iShares Core DAX® | -3.033% | -0.013% | 11.953% | 15.609% |
iShares Nasdaq 100 | -3.554% | -2.546% | 30.128% | 44.540% |
iShares Nikkei 225® | -3.938% | 2.183% | 11.741% | 8.345% |
iShares S&P 500 | -1.517% | -0.882% | 25.752% | 42.388% |
Comments by wiltrud for this prediction
In the thread Onyx Pharmaceuticals diskutieren
Bekommt Onyx die zweite Zulassung ?
kalifornische Biotech-Unternehmen steht vor der Zulassung seines zweiten Medikaments. Ein Erfolg könnte zu steigenden Kursen führen.
<!-- /BLOCK 4 -->
(Zielkurs erreicht)